SDM provides drug development, clinical research, and pharmacovigilance services.
SDM is a clinical research service provider based in Beijing, China, founded in 2005. It offers drug discovery and development support, registration services, clinical research, and pharmacovigilance to domestic and international clients across therapeutic areas including infection, oncology, immunology, vaccines, and respiratory and cardiovascular medicine. The company received strategic investments from Chengxin Venture Capital in May 2021 and Shiyu Capital and Fenghua Capital in December 2021, and closed another strategic investment in February 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in